Set the Record Straight on Ivermectin

The FDA recently issued a statement warning patients not to use the drug ivermectin, an off-patent drug for river blindness, to treat COVID-19, despite substantial evidence of its efficacy. The very next day, Merck announced positive results from a clinical trial on a new drug called molnupiravir in eliminating the virus in infected patients. Yet again, the FDA is working as Big Pharma’s partner in crime, attempting to deprive Americans of affordable and effective medications to protect drug companies’ bottom line.

Write to the FDA, with a copy to Congress, telling them to set the record straight on ivermectin.

Recipients

Your Senators
Your Representative
Food and Drug Administration

Contact

*Required fields

* Title:

* First Name:

* Last Name:

* Your Email:

* Address 1:

Address 2:

* City:

* State / Province:

* ZIP / Postal Code:

Country:

* Phone Number:

Yes, I would like to receive periodic updates and communications from Alliance for Natural Health USA.

Remember me. What's this?

Message

Please set the record straight on ivermectin

Dear [Decision Maker],

* Personalize your message

The FDA recently issued a statement warning patients not to use the drug ivermectin, an off-patent drug for river blindness, to treat COVID-19, despite substantial evidence of its efficacy.

There is evidence for ivermectin's usefulness against COVID.  A group of frontline doctors, the Frontline COVID-19 Critical Care Alliance (FLCCC), wrote a paper summarizing the evidence recommending the drug:

*All 8 available controlled trial results show statistically significant reductions in transmission;
*3 RCT's demonstrate large statistically significant reductions in transmission rates;
*5 RCT's show statistically significant impacts in time to recovery or hospital length of stay;
*1 RCT showed a large, statistically significant reduction in the rate of deterioration or hospitalization;
*3 RCT's showed large, statistically significant reductions in mortality.

Further, some researchers have noticed that African countries that had previously distributed ivermectin in mass campaigns to fight river blindness are experiencing lower infection and mortality rates from COVID-19.

In its statement, the FDA does not assess or comment on this impressive array of data. Rather, the agency simply states that there is a danger of overdosing on ivermectin, given it is also used on animals at higher doses which can be dangerous to humans. FLCC, on the other hand, report that ivermectin has a low rate of adverse events, with the majority being mild and transient. Serious adverse events were found in one study to occur in less than 1 percent of patients.

All of this underlines how broken the healthcare system in this country is. The government pushes expensive, often dangerous medicines for COVID (remember remdesivir?) and other illnesses while ignoring low-cost alternatives that either cannot be strongly patented or are off-patent.

Please correct the agency's statement on ivermectin.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]